Please check the individual session for location or broadcast availability.
Julie Nangia, MD
Eric Silberfein, MD
Target Audience and Needs
Medical oncologists, surgical oncologists, plastic surgeons, pathologists, radiologists, radiation oncologists, internists, general surgeons, and genetic counselors need to receive regular updates on the continually evolving advances in breast cancer management. The tumor board aims to increase the knowledge of learners by using a multidisciplinary case approach and follow-up recommendations to enhance the quality of breast cancer care and to improve patient outcomes.
Educational methods will include lectures, case presentations, literature review, and panel discussion.
At the conclusion of the sessions, the participants should be able to:
- Discuss how the roles of surgery and radiation have evolved in the local management of breast cancer.
- Utilize FDA-approved chemotherapy, targeted therapy, and immunotherapy to treat various types of breast cancer.
- Recognize the indications for germline and somatic genetic testing and incorporate the results into breast cancer management.
- Distinguish the roles of various types of breast cancer imaging in the diagnosis and management of breast cancer.
Participants may be asked to complete a session evaluation.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.